Grant: Project Grant
Institut de recherches cliniques de Montréal
$829,437.00
Metabolic flexibility in hepatic energy metabolism and steatotic liver disease
FY 2024-25
Summary
Our livers are responsible for storing, breaking down, and creating fuels to supply the body in times of energy demand. For example, when we fast, the liver breaks down stored fat and protein, turning them into forms of energy that can be used by other organs. To do this well, the liver listens to signals from many organs and can quickly alter its course when needs change (i.e. after we eat a meal). One way it senses these changes is by using a family of proteins called PGC-1As, which become activated when liver cells sense that other tissues need fuel. We recently found that some PGC-1A family members can also protect liver cells from damage, suggesting that these proteins have multiple important roles. Importantly, levels
of PGC-1A in liver are often low in people living with diabetes or steatotic liver disease.
Metabolic dysfunction associated steatotic liver disease (MASLD) affects about 25% of the Canadian population. The disease involves a build-up of fat in liver that is believed to cause inflammation and permanent scarring over time. MASLD increases risk of other diseases such as cardiovascular disease and cancer. Notably, 70-80% of people living with diabetes also have MASLD. We have shown that low PGC-1A in liver can worsen MASLD, and our new studies are designed to reveal important role(s) for PGC-1A in controlling energy demand and responses to stress. We will also investigate whether and how disruption of these function contributes to disease. Our project will help us better understand how the liver works, what goes wrong in MASLD, and why it is so closely linked to diabetes, in hopes of finding new ways to prevent, treat and cure these diseases.
Department
Program
Project Grant
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
510231
Name
Estall Jennifer
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Diabetes, Obesity, Lipid & Lipoprotein Disorders
Projecttitle
Metabolic flexibility in hepatic energy metabolism and steatotic liver disease
Programtype2
Operating Grants
Orgnameinp2
Institut de recherches cliniques de Montréal
Cihramount2
$829,437
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Fasting And Diet; Glucagon And Insulin; Glucose; Inflammation; Lipids; Liver; Masld; Metabolism; Mitochondria; Transcription
Abstract
Our livers are responsible for storing, breaking down, and creating fuels to supply the body in times of energy demand. For example, when we fast, the liver breaks down stored fat and protein, turning them into forms of energy that can be used by other organs. To do this well, the liver listens to signals from many organs and can quickly alter its course when needs change (i.e. after we eat a meal). One way it senses these changes is by using a family of proteins called PGC-1As, which become activated when liver cells sense that other tissues need fuel. We recently found that some PGC-1A family members can also protect liver cells from damage, suggesting that these proteins have multiple important roles. Importantly, levels
of PGC-1A in liver are often low in people living with diabetes or steatotic liver disease.
Metabolic dysfunction associated steatotic liver disease (MASLD) affects about 25% of the Canadian population. The disease involves a build-up of fat in liver that is believed to cause inflammation and permanent scarring over time. MASLD increases risk of other diseases such as cardiovascular disease and cancer. Notably, 70-80% of people living with diabetes also have MASLD. We have shown that low PGC-1A in liver can worsen MASLD, and our new studies are designed to reveal important role(s) for PGC-1A in controlling energy demand and responses to stress. We will also investigate whether and how disruption of these function contributes to disease. Our project will help us better understand how the liver works, what goes wrong in MASLD, and why it is so closely linked to diabetes, in hopes of finding new ways to prevent, treat and cure these diseases.
Competitiondate
202409
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Estall, Jennifer
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $829,437~ $0~